Skip to main content
. 2026 Apr 13;6:299. doi: 10.1038/s43856-026-01579-6

Table 4.

Participant Survey Results

Healthcare Provider Experiences with Implementing Genomic Medicine in a FQHC
N = 12
Did you review the GIRA reports with any of your patients?
YES n (%) NO n (%)
12 (100%) 0
What prevented you from reviewing a GIRA report with any of your patients? Check all that apply.
#
Lack of time 4
I get too many messages 1
I didn’t think it would be relevant 1
I didn’t think it would require changes in the management of my patient 3
I didn’t order it 2
I assumed the study staff were taking care of this 2
I didn’t know what it was 1
Other 4
A component of the GIRA is the polygenic risk score (PRS), which uses multiple genetic variants to assess a person’s risk of disease. In general, how confident are you…
Not at all n (%) A little n (%) Somewhat n (%) Very n (%)
…in your knowledge about PRS? 1 (8.3) 5 (41.6) 6 (50) 0
…in your ability to explain a PRS result to your patients? 0 3 (25) 8 (66.6) 1 (8.3)
…in your ability to make health care recommendations for your patients based on a PRS result? 0 3 (25) 5 (41.6) 4 (33.3)
After you reviewed the GIRA reports for your patients, how…
Not at all n (%) A little n (%) Somewhat n (%) Very n (%)
…understandable were the GIRA reports? 0 3 (25) 3 (25) 6 (50)
…valuable do you think the results on the GIRA report are for your patients’ medical care? 0 4 (33.3) 4 (33.3) 4 (33.3)
…does acting on the GIRA recommendations adversely affect your workflow? 6 (50) 5 (41.6) 1 (8.3) 0
… likely are you to act on the GIRA reports in your practice? 0 3 (25) 3 (25) 6 (50)
…likely will your patients make healthcare changes based on the GIRA recommendations? 0 7 (58.3) 4 (33.3) 1 (8.3)

Did you make any recommendations to your patients based on the findings from the GIRA reports?

Recommendations could include order test/s, change treatment, and/or recommend lifestyle change.

YES

n (%)

NO n (%)
12 (100%) 0